Michael Schrey

1.3k total citations
47 papers, 1.1k citations indexed

About

Michael Schrey is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Michael Schrey has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Genetics. Recurrent topics in Michael Schrey's work include Estrogen and related hormone effects (7 papers), Neuroendocrine regulation and behavior (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Michael Schrey is often cited by papers focused on Estrogen and related hormone effects (7 papers), Neuroendocrine regulation and behavior (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Michael Schrey collaborates with scholars based in United Kingdom, Germany and United States. Michael Schrey's co-authors include Kirti Patel, Ronald N. Rubin, Philip Steer, Philip Cornford, Roger Ekins, Rolf Kalff, Robert Kraft, Christian Beetz, B. L. Brown and Stephan Patt and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Michael Schrey

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Schrey United Kingdom 21 544 220 170 137 132 47 1.1k
Parvathi Nuthulaganti United States 13 536 1.0× 303 1.4× 104 0.6× 313 2.3× 96 0.7× 20 999
Simone Harbon France 22 816 1.5× 255 1.2× 60 0.4× 352 2.6× 139 1.1× 54 1.4k
A. Johns United States 16 582 1.1× 255 1.2× 90 0.5× 404 2.9× 73 0.6× 50 1.1k
Nino Mzhavia United States 17 674 1.2× 337 1.5× 128 0.8× 256 1.9× 65 0.5× 27 1.3k
Motoyoshi Sakaue Japan 16 902 1.7× 186 0.8× 76 0.4× 165 1.2× 86 0.7× 35 1.4k
Denis Leiber France 20 570 1.0× 165 0.8× 37 0.2× 182 1.3× 164 1.2× 36 987
Judith A. Creba United Kingdom 13 789 1.5× 235 1.1× 137 0.8× 203 1.5× 62 0.5× 23 1.4k
Akihiko Mishima Japan 4 964 1.8× 389 1.8× 68 0.4× 185 1.4× 146 1.1× 7 1.6k
Jacques Winand Belgium 18 588 1.1× 400 1.8× 115 0.7× 149 1.1× 30 0.2× 67 925
Irene Litosch United States 19 987 1.8× 329 1.5× 110 0.6× 214 1.6× 55 0.4× 40 1.5k

Countries citing papers authored by Michael Schrey

Since Specialization
Citations

This map shows the geographic impact of Michael Schrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schrey more than expected).

Fields of papers citing papers by Michael Schrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schrey. The network helps show where Michael Schrey may publish in the future.

Co-authorship network of co-authors of Michael Schrey

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schrey. A scholar is included among the top collaborators of Michael Schrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schrey. Michael Schrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schrey, Michael, Rüdiger Lange, Michael Städt, et al.. (2022). Assessing the feasibility of mapping the tibialis anterior muscle with navigated transcranial magnetic stimulation in neuro-oncologic patients. Scientific Reports. 12(1). 18719–18719. 4 indexed citations
2.
Schrey, Michael, et al.. (2016). Collision Tumor Composed of Meningioma and Cavernoma. Journal of Korean Neurosurgical Society. 60(1). 102–107. 13 indexed citations
3.
Rehman, Farah, et al.. (2005). Aromatase inhibition by 15-deoxy-prostaglandin J2 (15-dPGJ2) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production. The Journal of Steroid Biochemistry and Molecular Biology. 94(1-3). 159–165. 13 indexed citations
4.
Rehman, Farah, P. Shanmugasundaram, & Michael Schrey. (2004). Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity. British Journal of Cancer. 91(10). 1821–1828. 33 indexed citations
5.
Schrey, Michael, et al.. (2003). CYCLOSPORIN A ENHANCES CERAMIDE SIGNALLING IN HUMAN BREAST CANCER CELLS IN RESPONSE TO N-(4-HYDROXYPHENYL) RETINAMIDE. 6. 1 indexed citations
6.
Schrey, Michael, et al.. (2002). Prostaglandin J2 metabolites inhibit aromatase activity by redox‐sensitive mechanisms: Potential implications for breast cancer therapy. International Journal of Cancer. 103(5). 600–605. 13 indexed citations
7.
Donnelly, Neil, et al.. (1998). Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells. Breast Cancer Research and Treatment. 48(2). 117–124. 4 indexed citations
11.
Schrey, Michael, et al.. (1994). Role of regulatory peptides in the control of breast cancer cell growth and function. Endocrine Related Cancer. 1(3). 41–70. 5 indexed citations
12.
Schrey, Michael, et al.. (1992). Endothelin-1 stimulates phospholipid hydrolysis and prostaglandin F2α production in primary human decidua cell cultures. Prostaglandins Leukotrienes and Essential Fatty Acids. 47(4). 321–325. 12 indexed citations
13.
Schrey, Michael, Kirti Patel, & Nikolaos Tezapsidis. (1992). Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells.. PubMed. 52(7). 1786–90. 47 indexed citations
14.
Patel, Kirti & Michael Schrey. (1991). Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist. Journal of Molecular Endocrinology. 6(1). 71–78. 9 indexed citations
15.
Patel, Kirti & Michael Schrey. (1990). Activation of inositol phospholipid signaling and Ca2+ efflux in human breast cancer cells by bombesin.. PubMed. 50(2). 235–9. 38 indexed citations
16.
Lai, Leslie C., Mohammad A. Ghatei, Kazuhiro Takahashi, et al.. (1990). Mitogenic peptides in breast cyst fluid: Relationship with intracystic electrolyte ratios. International Journal of Cancer. 46(6). 1014–1016. 18 indexed citations
17.
Schrey, Michael, et al.. (1988). Cholinergic stimulation of phosphoinositide hydrolysis in rat anterior pituitary. Molecular and Cellular Endocrinology. 57(1-2). 107–113. 4 indexed citations
19.
Schrey, Michael, Richard C. Franson, & Ronald N. Rubin. (1980). Further characterization of Ca2+-activated phospholipase A2 in cat adrenal cortex. Cell Calcium. 1(2). 91–104. 8 indexed citations
20.
Rubin, Ronald N., et al.. (1979). Secretagogues for lysosomal enzyme release as stimulants of arachidonyl phosphatidylinositol turnover in rabbit neutrophils. Biochemical and Biophysical Research Communications. 90(4). 1364–1370. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026